SANGUI BIO PTY LTD has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are MEDICAL TECHNOLOGY CORP, UHLEN MATHIAS and HAZEN STANLEY L.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | China | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | United States | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Republic of Korea | 2 | |
#8 | Singapore | 2 | |
#9 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Karsten Elisabeth | 23 |
#2 | Liddle Alan | 17 |
#3 | Herbert Ben | 17 |
#4 | Hill Cameron | 17 |
#5 | Herbert Benjamin Ross | 6 |
Publication | Filing date | Title |
---|---|---|
EP3559253A1 | Blood profiling with protease inhibitors | |
CN108883133A | Use the treatment method of red blood cell | |
CA3001154A1 | Blood preparation and profiling |